(DEAM) Invesco MDAX Acc - Ratings and Ratios
Stocks, SmallCap, MidCap, Equity, Germany
Description: DEAM Invesco MDAX Acc
The Invesco MDAX UCITS ETF Acc is an exchange-traded fund listed on XETRA, tracking the MDAX index, which comprises mid-cap German companies. As a Germany Small/Mid-Cap Equity ETF, it provides investors with exposure to a segment of the German market that is often characterized by its growth potential.
To evaluate the performance of DEAM, key performance indicators (KPIs) such as tracking error, expense ratio, and dividend yield can be considered. A low tracking error would indicate that the ETF is effectively replicating the MDAX index. The expense ratio, which is likely to be relatively low given the ETFs structure, is a crucial factor in determining the net returns to investors. Additionally, the dividend yield, which is influenced by the dividend policies of the constituent companies, can provide insights into the income generation potential of the ETF.
From a portfolio management perspective, DEAM can be used to gain targeted exposure to the German mid-cap market, potentially diversifying a portfolio and enhancing its risk-return profile. Investors seeking to allocate to this specific segment can use DEAM as a standalone investment or as a component of a broader portfolio strategy. The liquidity of the ETF, as reflected in its trading volume and market capitalization (AUM: 1655.12M EUR), is also an essential consideration for investors, as it affects the ease of entering or exiting positions.
To further analyze DEAM, investors can examine its sector and industry allocations, which are derived from the MDAX index composition. This analysis can help identify potential concentration risks or opportunities for growth. Moreover, comparing DEAMs performance to that of its benchmark and peers can provide valuable insights into its relative strengths and weaknesses.
Additional Sources for DEAM ETF
DEAM ETF Overview
Market Cap in USD | 1,934m |
Category | Germany Small/Mid-Cap Equity |
TER | 0.19% |
IPO / Inception | 2019-02-11 |
DEAM ETF Ratings
Growth Rating | 4.72 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -6.48 |
Analysts | - |
Fair Price Momentum | 50.90 EUR |
Fair Price DCF | - |
DEAM Dividends
Currently no dividends paidDEAM Growth Ratios
Growth Correlation 3m | 69.1% |
Growth Correlation 12m | 82.3% |
Growth Correlation 5y | -53.2% |
CAGR 5y | 2.45% |
CAGR/Max DD 5y | 0.06 |
Sharpe Ratio 12m | 2.06 |
Alpha | 12.27 |
Beta | 0.583 |
Volatility | 15.31% |
Current Volume | 40.7k |
Average Volume 20d | 40.7k |
Stop Loss | 50.1 (-3%) |
As of July 15, 2025, the stock is trading at EUR 51.64 with a total of 40,730 shares traded.
Over the past week, the price has changed by +1.41%, over one month by +3.90%, over three months by +16.70% and over the past year by +20.85%.
Neither. Based on ValueRay´s Analyses, Invesco MDAX Acc is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 4.72 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DEAM is around 50.90 EUR . This means that DEAM is currently overvalued and has a potential downside of -1.43%.
Invesco MDAX Acc has no consensus analysts rating.
According to our own proprietary Forecast Model, DEAM Invesco MDAX Acc will be worth about 57.1 in July 2026. The stock is currently trading at 51.64. This means that the stock has a potential upside of +10.5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 57.1 | 10.5% |